Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H27N3O |
| Molecular Weight | 313.4372 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCN1C=C(C(=O)N2CCN(C)CC2)C3=C1C=CC=C3
InChI
InChIKey=IUEFFEOHJKCBPF-UHFFFAOYSA-N
InChI=1S/C19H27N3O/c1-3-4-7-10-22-15-17(16-8-5-6-9-18(16)22)19(23)21-13-11-20(2)12-14-21/h5-6,8-9,15H,3-4,7,10-14H2,1-2H3
| Molecular Formula | C19H27N3O |
| Molecular Weight | 313.4372 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:19:27 GMT 2023
by
admin
on
Sat Dec 16 10:19:27 GMT 2023
|
| Record UNII |
W6OZW1T05K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-MEPIRAPIM
Created by
admin on Sat Dec 16 10:19:27 GMT 2023 , Edited by admin on Sat Dec 16 10:19:27 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
W6OZW1T05K
Created by
admin on Sat Dec 16 10:19:27 GMT 2023 , Edited by admin on Sat Dec 16 10:19:27 GMT 2023
|
PRIMARY | |||
|
101896603
Created by
admin on Sat Dec 16 10:19:27 GMT 2023 , Edited by admin on Sat Dec 16 10:19:27 GMT 2023
|
PRIMARY | |||
|
2365542-29-4
Created by
admin on Sat Dec 16 10:19:27 GMT 2023 , Edited by admin on Sat Dec 16 10:19:27 GMT 2023
|
PRIMARY | |||
|
MEPIRAPIM
Created by
admin on Sat Dec 16 10:19:27 GMT 2023 , Edited by admin on Sat Dec 16 10:19:27 GMT 2023
|
PRIMARY | MEPIRAPIM is a indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group(1) and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA. | ||
|
MEPIRAPIM
Created by
admin on Sat Dec 16 10:19:27 GMT 2023 , Edited by admin on Sat Dec 16 10:19:27 GMT 2023
|
PRIMARY | MEPIRAPIM is a indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group(1) and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA. Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET->WEAK AGONIST |
Ki
|
||
|
|
TARGET->WEAK AGONIST |
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
